Immunome, Inc.Immunome, Inc.Immunome, Inc.

Immunome, Inc.

No trades
See on Supercharts

Price target

32.500.00 0.00%
The 4 analysts offering 1 year price forecasts for IMNM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to IMNM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

IMNM EPS for the last quarter is −4.21 USD despite the estimation of −0.27 USD. In the next quarter EPS is expected to reach −0.68 USD. Track more of Immunome, Inc. financials and stay on top of what is up with the company.
In the next quarter Immunome, Inc. revenue is expected to reach ‪2.80 M‬ USD. Check out Immunome, Inc. revenue and earnings and make informed decisions.
According to analysts, IMNM price target is 32.50 USD with a max estimate of 38.00 USD and a min estimate of 24.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with IMNM news and stock market news.
We've gathered opinions of 5 analysts rating IMNM stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.